Ben Goldacre

21.0k total citations · 1 hit paper
140 papers, 4.3k citations indexed

About

Ben Goldacre is a scholar working on General Health Professions, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, Ben Goldacre has authored 140 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in General Health Professions, 41 papers in Public Health, Environmental and Occupational Health and 37 papers in Economics and Econometrics. Recurrent topics in Ben Goldacre's work include Health Systems, Economic Evaluations, Quality of Life (29 papers), Healthcare cost, quality, practices (19 papers) and Pharmaceutical industry and healthcare (18 papers). Ben Goldacre is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (29 papers), Healthcare cost, quality, practices (19 papers) and Pharmaceutical industry and healthcare (18 papers). Ben Goldacre collaborates with scholars based in United Kingdom, United States and Netherlands. Ben Goldacre's co-authors include Nicholas DeVito, Kamal R Mahtani, Carl Heneghan, Helen J Curtis, Liam Smeeth, Seb Bacon, Tjeerd van Staa, Alex J Walker, Richard Croker and Carl Heneghan and has published in prestigious journals such as Nature, The Lancet and JAMA.

In The Last Decade

Ben Goldacre

133 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Why clinical trial outcomes fail to translate into benefits for patients

2017 227 citations Carl Heneghan, Ben Goldacre et al. profile →

Peers

Countries citing papers authored by Ben Goldacre

Since Specialization

Citations

This map shows the geographic impact of Ben Goldacre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Goldacre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Goldacre more than expected).

Fields of papers citing papers by Ben Goldacre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Goldacre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Goldacre. The network helps show where Ben Goldacre may publish in the future.

Co-authorship network of co-authors of Ben Goldacre

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Goldacre. A scholar is included among the top collaborators of Ben Goldacre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Goldacre. Ben Goldacre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Variation in duration of repeat prescriptions: a primary care cohort study in England 2025 ·British Journal of General Practice ·Brian MacKenna, (unknown), Richard Croker, Alex J Walker, Ben Goldacre, Apostolos Tsiachristas, (unknown), Peter Inglesby, Seb Bacon, Helen J Curtis	0
2	The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19 2024 ·Journal of Infection ·Katie Bechman, Amelia Green, Mark Russell, (unknown), Bang Zheng, Sam Norton, Rebecca Smith, Amir Mehrkar, (unknown), Ben Goldacre, Brian MacKenna, James Galloway	1
3	Ursodeoxycholic acid and severe COVID-19 outcomes in a cohort study using the OpenSAFELY platform 2024 ·SHILAP Revista de lepidopterología ·Ruth Costello, (unknown), Rachel J. Smith, George Mells, Angel Wong, Anna Schultze, Viyaasan Mahalingasivam, Emily Herrett, Bang Zheng, Liang-Yu Lin, (unknown), Amir Mehrkar, Seb Bacon, Ben Goldacre, Laurie A. Tomlinson, John Tazare, Christopher T. Rentsch, (unknown), (unknown)	0
4	Weight trends among adults with diabetes or hypertension during the COVID-19 pandemic: an observational study using OpenSAFELY 2024 ·British Journal of General Practice ·Miriam Samuel, (unknown), Sophie V. Eastwood, (unknown), Caroline E Morton, Daniel Stow, Seb Bacon, Ben Goldacre, Amir Mehrkar, Jessica Morley, Iain Dillingham, Peter Inglesby, William Hulme, Kamlesh Khunti, Rohini Mathur, Jonathan Valabhji, Brian MacKenna, Sarah Finer, (unknown)	1
5	Exploring Prior Antibiotic Exposure Characteristics for COVID-19 Hospital Admission Patients: OpenSAFELY 2024 ·Antibiotics ·(unknown), David Wong, (unknown), (unknown), Darren M. Ashcroft, Kieran Hand, Jon Massey, Brian MacKenna, Amir Mehrkar, Seb Bacon, Ben Goldacre, Victoria Palin, Tjeerd van Staa	1
6	Identification of patients undergoing chronic kidney replacement therapy in primary and secondary care data: validation study based on OpenSAFELY and UK Renal Registry 2024 ·SHILAP Revista de lepidopterología ·Shalini Santhakumaran, Louis Fisher, (unknown), Viyaasan Mahalingasivam, Lucy Plumb, Edward P K Parker, Retha Steenkamp, Caroline E Morton, Amir Mehrkar, Seb Bacon, (unknown), (unknown), Ben Goldacre, Brian MacKenna, Laurie A. Tomlinson, Dorothea Nitsch	2
7	Evaluation of the impact of COVID-19 pandemic on hospital admission related to common infections: Risk prediction models to tackle antimicrobial resistance in primary care 2024 ·PLoS ONE ·(unknown), Victoria Palin, (unknown), (unknown), (unknown), Darren M. Ashcroft, Ben Goldacre, (unknown), Louis Fisher, Jon Massey, Amir Mehrkar, Seb Bacon, (unknown), Kieran Hand, Tjeerd van Staa	1
8	Effectiveness of mRNA COVID-19 Vaccines as First Booster Doses in England: An Observational Study in OpenSAFELY-TPP 2024 ·Epidemiology ·Elsie Horne, William Hulme, Edward P K Parker, Ruth H. Keogh, Elizabeth Williamson, Venexia Walker, Tom Palmer, Rachel Denholm, Rochelle Knight, Helen J Curtis, Alex J Walker, Colm Andrews, Amir Mehrkar, Jessica Morley, Brian MacKenna, Seb Bacon, Ben Goldacre, Miguel A. Hernán, Jonathan A C Sterne, (unknown)	1
9	The impact of COVID-19 on antibiotic prescribing in primary care in England: Evaluation and risk prediction of appropriateness of type and repeat prescribing 2023 ·Journal of Infection ·(unknown), Alexander Pate, (unknown), (unknown), Darren M. Ashcroft, Ben Goldacre, Brian MacKenna, Amir Mehrkar, Seb Bacon, Jon Massey, Louis Fisher, Peter Inglesby, Kieran Hand, Tjeerd van Staa, Victoria Palin	7
10	Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study 2023 ·The Lancet Regional Health - Europe ·Edward P K Parker, Elsie Horne, William Hulme, John Tazare, Bang Zheng, Edward J Carr, Fiona Loud, (unknown), Viyaasan Mahalingasivam, Brian MacKenna, Amir Mehrkar, (unknown), Shalini Santhakumaran, Retha Steenkamp, Ben Goldacre, Jonathan A C Sterne, Dorothea Nitsch, Laurie A. Tomlinson	8
11	Impact of COVID-19 on broad-spectrum antibiotic prescribing for common infections in primary care in England: a time-series analyses using OpenSAFELY and effects of predictors including deprivation 2023 ·The Lancet Regional Health - Europe ·(unknown), Alexander Pate, (unknown), (unknown), Darren M. Ashcroft, Ben Goldacre, Brian MacKenna, Amir Mehrkar, Seb Bacon, Jon Massey, Louis Fisher, Peter Inglesby, Kieran Hand, Tjeerd van Staa, Victoria Palin	10
12	The Use of Online Consultation Systems or Remote Consulting in England Characterized Through the Primary Care Health Records of 53 Million People in the OpenSAFELY Platform: Retrospective Cohort Study 2023 ·JMIR Public Health and Surveillance ·Martina Fonseca, Brian MacKenna, Amir Mehrkar, (unknown), Caroline E. Walters, George Hickman, (unknown), Louis Fisher, Peter Inglesby, Seb Bacon, Simon Davy, William Hulme, Ben Goldacre, (unknown), (unknown)	1
13	Trends and variation in data quality and availability on the European Union Clinical Trials Register: A cross-sectional study 2022 ·Clinical Trials ·Nicholas DeVito, Ben Goldacre	9
14	Sales of Over-the-Counter Products Containing Codeine in 31 Countries, 2013–2019: A Retrospective Observational Study 2022 ·Drug Safety ·Georgia C. Richards, Jeffrey K Aronson, Brian MacKenna, Ben Goldacre, Richard Hobbs, Carl Heneghan	13
15	Software development skills for health data researchers 2022 ·BMJ Health & Care Informatics ·Caroline E Morton, Nicholas DeVito, Jessica Morley, Iain Dillingham, Anna Schultze, Seb Bacon, Peter Inglesby, (unknown), Ben Goldacre	1
16	Identifying Patterns of Clinical Interest in Clinicians’ Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for Clinical Review 2022 ·JMIR Medical Informatics ·Brian MacKenna, Helen J Curtis, Lisa Hopcroft, Alex J Walker, Richard Croker, Orla Macdonald, Stephen Evans, Peter Inglesby, David Evans, Jessica Morley, Seb Bacon, Ben Goldacre	0
17	Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials 2021 ·BMJ ·Emily Herrett, Elizabeth Williamson, Kieran E. Brack, Danielle Beaumont, Alexander Perkins, Andrew Thayne, Haleema Shakur‐Still, Ian Roberts, Danielle Prowse, Ben Goldacre, Tjeerd van Staa, Thomas M. MacDonald, Jane Armitage, (unknown), P.A. Melrose, (unknown), (unknown), Michael Moore, Maurice Hoffman, Liam Smeeth	114
18	The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTs 2021 ·Health Technology Assessment ·Emily Herrett, Elizabeth Williamson, Kieran E. Brack, Alexander Perkins, Andrew Thayne, Haleema Shakur‐Still, Ian Roberts, Danielle Prowse, Danielle Beaumont, Zahra Jamal, Ben Goldacre, Tjeerd van Staa, Thomas M. MacDonald, Jane Armitage, Michael Moore, Maurice Hoffman, Liam Smeeth	3
19	Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials 2019 ·BMJ Open ·Igho Onakpoya, Elizabeth T Thomas, Joseph Lee, Ben Goldacre, Carl Heneghan	80
20	Prevalence of clinical trial status discrepancies: A cross-sectional study of 10,492 trials registered on both ClinicalTrials.gov and the European Union Clinical Trials Register 2018 ·PLoS ONE ·Jessica Fleminger, Ben Goldacre	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact